glp 1 agonist cardiovascular outcomes GLP-1 receptor versus DPP-4 inhibitor and kidney and in clinical practice in type-2 diabetes Real-World Evidence for GLP-1 Receptor

1997, 13: 52S-57S

Thus, our attention instead focused on proteins and BSA was a likely candidate

Future research should focus on precisely revealing the dynamic changes of inflammation and oxidative stress at different stages of osteoporosis, identifying specific biomarkers, and developing new drugs that can selectively regulate these pathways

Radiotherapy inhibits tumor growth by generally inducing tumor cell apoptosis, senescence, autophagy, necrosis, or mitotic catastrophe through inflicting extensive DNA damages (Baskar et al., 2012

50: 884888, doi: Hofmann M, Schober-Halper B, Oesen S, Franzke B, Tschan H, Bachl N, Strasser EM, Quittan M, Wagner KH, Wessner B